{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:27:36Z","timestamp":1770816456791,"version":"3.50.1"},"reference-count":11,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2003,6,1]],"date-time":"2003-06-01T00:00:00Z","timestamp":1054425600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.liebertpub.com\/nv\/resources-tools\/text-and-data-mining-policy\/121\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Biotherapy and Radiopharmaceuticals"],"published-print":{"date-parts":[[2003,6]]},"DOI":"10.1089\/108497803322285107","type":"journal-article","created":{"date-parts":[[2003,9,4]],"date-time":"2003-09-04T01:14:00Z","timestamp":1062638040000},"page":"355-363","source":"Crossref","is-referenced-by-count":27,"title":["Labeling\n                    <i>anti-HER2\/neu<\/i>\n                    Monoclonal Antibodies with\n                    <sup>111<\/sup>\n                    In and\n                    <sup>90<\/sup>\n                    Y Using a Bifunctional DTPA Chelating Agent"],"prefix":"10.1177","volume":"18","author":[{"given":"Michael J.","family":"Blend","sequence":"first","affiliation":[{"name":"Department of Radiology, Section of Nuclear Medicine, College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry J.","family":"Stastny","sequence":"additional","affiliation":[{"name":"Department of Radiology, Section of Nuclear Medicine, College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven M.","family":"Swanson","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, University of Illinois at Chicago, Chicago, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin W.","family":"Brechbiel","sequence":"additional","affiliation":[{"name":"ROB, NCI, NIH, Bethesda, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"p_5","doi-asserted-by":"publisher","DOI":"10.1126\/science.3798106"},{"key":"p_6","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.82.19.6497"},{"key":"p_7","doi-asserted-by":"publisher","DOI":"10.1126\/science.2470152"},{"key":"p_8","first-page":"63","volume":"13","author":"Pauletti G","year":"1996","journal-title":"Oncogene"},{"key":"p_9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.9.2639"},{"key":"p_10","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.10.4285"},{"key":"p_11","first-page":"60","volume":"26","author":"Sliwkowski MX","year":"1999","journal-title":"Semin Oncol"},{"key":"p_14","doi-asserted-by":"publisher","DOI":"10.1021\/bc00022a005"},{"key":"p_15","doi-asserted-by":"publisher","DOI":"10.1021\/bc00016a014"},{"key":"p_16","doi-asserted-by":"publisher","DOI":"10.1016\/S0968-0896(97)00130-2"},{"key":"p_17","doi-asserted-by":"publisher","DOI":"10.1016\/0969-8051(94)00126-5"}],"container-title":["Cancer Biotherapy and Radiopharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.liebertpub.com\/doi\/pdf\/10.1089\/108497803322285107","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T10:32:42Z","timestamp":1770805962000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1089\/108497803322285107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,6]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,6]]}},"alternative-id":["10.1089\/108497803322285107"],"URL":"https:\/\/doi.org\/10.1089\/108497803322285107","relation":{},"ISSN":["1084-9785","1557-8852"],"issn-type":[{"value":"1084-9785","type":"print"},{"value":"1557-8852","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,6]]}}}